Genetic and antigenic analysis of Getah virus isolated in 1978 and 2014 in Japan  by Nemoto, M. et al.
10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S20eS22 S21of the C. obsoletus complex, C. chiopterus, C. dewulﬁ and C. punc-
tatus was 0.7, 0.4, 0.5 and 7.8 midges/minute, respectively. The
overall biting rate (BR) was however low, with only 4.6% of the
more than 5,000 midges captured off the horses found freshly
blood-engorged. Both C. chiopterus and C. dewulﬁ were reared
from the dung of the two experimental horses.
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Background: Globally there has been increasing concern over
emerging infectious diseases. In particular arboviral diseases
represent a signiﬁcant threat to animal and human health and the
introduction of West Nile virus into North America has demon-
strated the potentially signiﬁcant effects of these viruses on a
naïve host population. In Europe recent arboviral emergence
events include Usustu, chikingunya, and dengue and in the UK,
bluetongue and Schmallenberg viruses. A number of arboviruses
affecting horses have been noted as important zoonoses with
potential for emergence in Europe, including Japanese encepha-
litis virus, Eastern equine encephalitis virus, Western equine en-
cephalitis virus and Venezuelan equine encephalitis virus. West
Nile virus already causes outbreaks in equines in Europe including
in Northern Italy and Southern France in 2015. Information
regarding the species presence and numbers of mosquitoes on
equine premises in the UK are lacking. This information is
important in assessing the future risk to horses from mosquito
borne disease. The purpose of this study was to add to informa-
tion on mosquito presence and abundance on equine premises
and to investigate the practicalities of mosquito surveillance
techniques on equine premises in the UK. Initial ﬁeldwork has
concentrated on the species and relative numbers of mosquitoes
present on equine premises and to provide baseline information
for future mosquito surveillance. This study involved mosquito
sampling on 8 premises in each of 4 widely distributed regions of
England. Stratiﬁed sampling of four mosquito habitats in prox-
imity to equine premises was utilised: Fenland, Woodland, Urban,
and Saltmarsh. Each region was visited 3 times during the mos-
quito season and the timing of these visits was based around the
average peaks of different mosquito species abundance. The main
trap used for sampling was the Mosquito Magnet™ and this was
run for approximately 72 hours at each visit. Larval sampling and
a resting box trapwere also used on all sites, and restingmosquito
sampling, and sweep netting were also used where appropriate.
Mosquitoes were identiﬁed as far as possible morphologically and
by molecular methods for the Culex pipiens complex. Preliminary
results indicate that species presence is highly correlated with
expected presence based on proximity to mosquito breeding
habitat. Cx pipiens complex mosquitoes and Culiseta annulata
were two of the most commonly found species. Further conclu-
sions may be drawn after completion of the study and analysis of
data.
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Non-primate hepaciviruses (NPHVs) that infect horses are the
closest relatives of hepatitis C virus (HCV) described to date. HCV
and NPHV belong to the genus Hepacivirus, within the family
Flaviviridae of single-stranded, positive sense RNA viruses. In this
study, we analyzed the NPHV prevalence in stallions, broodmares
and yearlings in Japan. We used 35 serum samples from stallions
at Farm A and 122 and 125 serum samples from broodmares and
yearlings at Farm B and Farm C, respectively, obtained in
November 2013. All of the horses were Thoroughbred. Most of the
yearlings were reared at Fam B with their dams until 6 to 7
months of age, and then moved to Farm C. NPHV RNA in serum
samples was detected by a nested RT-PCR targeting conserved
sequences in the nonstructural 3 (NS3) protein coding region.
Four (11.4%) of the 35 stallions, 7 (5.8%) of the 122 broodmares
and 4 (3.2%) of the 125 yearlings were NPHV RNA-positive. The
NS3 region sequences of all 15 NPHV RNA-positive PCR products
were determined. Phylogenetic analysis showed that all of the 15
NS3 sequences clustered with sequences previously classiﬁed as
NPHV. The analysis revealed that vertical transmission from one
broodmare to her infant and horizontal transmission among
yearlings occurred. A retrospective and follow-up survey of NPHV
RNA-positive horses revealed that most of the horses had chronic
infection and that only a few horse had acute infection. Two
horses showed viremia over a ten-year period. In 4 NPHV RNA-
positive stallions, GGT, AST and LDH levels in serum were almost
all within reference ranges. Therefore, hepatitis was not observed.
This study suggested that NPHV infections are widespread in
Japanese horses as well as in horses in other countries, such as UK,
Germany, USA and Brazil, and that both vertical transmission and
horizontal transmission occur.
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Getah virus is a mosquito-borne virus that causes fever, rash on
the body, and edema of the legs in horses and pigs. An inactivated
vaccine has been used since the ﬁrst outbreak occurred in 1978 at
the Miho training center of the Japan Racing Association, and no
outbreaks had occurred in vaccinated horses until 2014, when the
disease resurfaced among racehorses at the same training center
in September and October of that year [1]. As we reported pre-
viously [2], indirect causes of this outbreak likely include the
existence of susceptible horses that have not completed the
vaccination program and an increased risk of exposure to the
virus because of epizootic Getah virus infection around the
training center. However, the direct cause of the 2014 outbreak
remains unclear. To determine whether mutation of the virus was
directly responsible for the outbreak, we performed genetic and
antigenic analysis of the vaccine strain (MI-110) isolated in 1978
and a strain isolated in 2014 (14-I-605). We sequenced the com-
plete genomes of two cloned MI-110 strains and two cloned 14-I-
605 strains. In addition, the original MI-110 and 14-I-605 were
inoculated into seronegative horses. Antisera collected from these
horses were used in a cross-neutralizing test. The complete
genome sequences of the cloned 14-I-605 strains had 98.6%
nucleotide identity to those of the cloned MI-110 strains. The
nucleotide lengths of non-structural polyprotein (nsP1234, 7404
10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S20eS22S22base pairs) and structural polyprotein (C-E3-E2-6K-E1, 3762 base
pairs) were identical between MI-110 and 14-I-605. The nucleo-
tide and amino acid sequences of these genes were highly
conserved between MI-110 and 14-I-605 (nsP1234, 98.5% for
nucleotides and 99.5% for amino acids; C-E3-E2-6K-E1, 98.7% for
nucleotides and 99.8% to 99.9% for amino acids). Antisera against
MI-110 and 14-I-605 had almost equal titers against both the
homologous virus and the heterologous virus. These results
showed that there was little difference between MI-110 and 14-I-
605 genetically and antigenically. Therefore, the current vaccine
containing MI-110 should be effective against 14-I-605, and it is
unlikely that virus mutation was a direct cause of the 2014
outbreak.
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Institut Pasteur, 75 Paris, FranceHepatitis C virus (HCV) is one of the main causes of end stage
liver diseases (cirrhosis and hepatocellular carcinoma) in
humans. In vivo studies have been hampered by a lack of access
to relevant animal models. Until recently, the genus Hepacivirus
was comprised of seven HCV genotypes, plus GBV-B that infects
New World monkeys. Within the past few years, new hep-
aciviruses were identiﬁed in dogs and horses (also called
canine/equine or non-primate hepaciviruses), in Old World
monkeys (Colobus guereza), as well as in rodents (Myodes
glareolus and Rhabdomys pumilio) and bats. Yet, the data
available regarding newly identiﬁed hepacivirus infections is
still limited, including in horses. So far, few studies have re-
ported PCR positive horses in different countries (USA, Scot-
land, Germany, Japan, Brazil and Hungary). The aim of our study
was to determine the prevalence of active hepacivirus in-
fections in horses. A RT-qPCR adapted from the test described
by Burbello et al. was developed according to the AFNOR norm
U47-600-2. We detected 69 positive horses out of 1229
screened with this assay (5,6%). Positive horse samples origi-
nated from all parts of France. The number of viral genomes
circulating in the blood of hepacivirus-infected horses ranged
from 1.15 x 104 to 2.8 x 109 copies/mL, with two third of the
results above a threshold of 4.26 x 107 copies/mL. There was no
evidence of concomitant hepatic inﬂammation in the sera, as
tested by the levels of gamma-glutamyl transferase and gluta-
mate deshydrogenase. A one-year follow-up study in 7 horses
from the same stud farm showed that, from the time of
detection, infection persisted up to 18 months. A phylogenetic
analysis was performed based on the nucleotide sequences of
the 5’-untranslated region of the genome, as well as of the
genes encoding the nonstructural proteins 3 and 5B. The result
of this analysis suggests that all positive horses identiﬁed in
France are infected with equine hepacivirus variants distinct
from those previously reported. The present study demon-
strates for the ﬁrst time the presence of a signiﬁcant proportion
of ongoing equine hepacivirus infections in the horse herds in
France. Determining the consequences of persistent hepacivirus
infections in horses warrants further investigation.
